{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T22:03:55Z","timestamp":1766181835860,"version":"3.40.4"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>There have been no formal studies of the use of collagenase clostridium histolyticum (Xiaflex; Endo Pharmaceuticals, Malvern, Pa.) in the anticoagulated patient. Previous study on its use excluded patients receiving anticoagulation therapy. This study reviewed the effects of anticoagulation use in patients undergoing collagenase clostridium histolyticum injection and cord rupture to determine safety and efficacy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The authors retrospectively reviewed patients receiving collagenase clostridium histolyticum injections for Dupuytren contracture between 2010 and 2017. Outcomes included type of anticoagulation, skin tear, tendon rupture, lymphadenopathy, sensory abnormality, hematoma, and bleeding.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 388 injections were performed in 197 patients. The average clinical follow-up was 311 days. Fifty-two percent of patients (<jats:italic toggle=\"yes\">n<\/jats:italic> = 201) were anticoagulated. The vast majority were taking aspirin (acetylsalicylic acid) (<jats:italic toggle=\"yes\">n<\/jats:italic> = 182), followed by warfarin (<jats:italic toggle=\"yes\">n<\/jats:italic> = 27), clopidogrel (<jats:italic toggle=\"yes\">n<\/jats:italic> = 9), apixaban (<jats:italic toggle=\"yes\">n<\/jats:italic> = 8), rivaroxaban (<jats:italic toggle=\"yes\">n<\/jats:italic> = 4), and dabigatran (<jats:italic toggle=\"yes\">n<\/jats:italic> = 2). There were 42 skin tears, 21 in the anticoagulated group. One tendon rupture occurred in the anticoagulated group (acetylsalicylic acid) and none occurred in the nonanticoagulated group (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.34). No patients experienced sensory abnormalities, a hematoma requiring intervention, or uncontrollable bleeding.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Anticoagulation is commonly encountered by hand surgeons treating Dupuytren contracture. There is no significant difference in complications in the anticoagulated patient versus the nonanticoagulated patient. It is safe to perform collagenase clostridium histolyticum injections for Dupuytren contracture in the anticoagulated patient, regardless of the type of anticoagulation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CLINICAL QUESTION\/LEVEL OF EVIDENCE:<\/jats:title>\n            <jats:p>Therapeutic, III.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/prs.0000000000009038","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T21:00:36Z","timestamp":1646946036000},"page":"914e-920e","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["The Effect of Anticoagulation on the Treatment of Dupuytren Contracture with Collagenase"],"prefix":"10.1097","volume":"149","author":[{"given":"Shelley S.","family":"Noland","sequence":"first","affiliation":[{"name":"From the Mayo Clinic."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron W.","family":"Paul","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lacey R.","family":"Pflibsen","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Rizzo","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,3,11]]},"reference":[{"key":"R1-20250501","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jhsa.2007.04.002","article-title":"Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren\u2019s contracture.","volume":"32","author":"Badalamente","year":"2007","journal-title":"J Hand Surg Am"},{"key":"R2-20250501","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jhsa.2015.02.018","article-title":"Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in Dupuytren contracture: Combined analysis of 4 phase 3 clinical trials.","volume":"40","author":"Badalamente","year":"2015","journal-title":"J Hand Surg Am"},{"key":"R3-20250501","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/jamasurg.2016.3605","article-title":"Treatment of Dupuytren contracture with injectable collagenase within the Veterans Affairs system.","volume":"152","author":"Duquette","year":"2017","journal-title":"JAMA Surg"},{"key":"R4-20250501","doi-asserted-by":"crossref","first-page":"e657","DOI":"10.3928\/01477447-20140626-64","article-title":"Multiple collagenase injections are safe for treatment of Dupuytren\u2019s contractures.","volume":"37","author":"Gajendran","year":"2014","journal-title":"Orthopedics"},{"key":"R5-20250501","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.jhsa.2015.06.099","article-title":"The efficacy and safety of concurrent collagenase clostridium histolyticum injections for 2 Dupuytren contractures in the same hand: A prospective, multicenter study.","volume":"40","author":"Gaston","year":"2015","journal-title":"J Hand Surg Am"},{"key":"R6-20250501","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.hcl.2013.08.016","article-title":"Collagenase injections for treatment of Dupuytren disease.","volume":"30","author":"Hentz","year":"2014","journal-title":"Hand Clin"},{"key":"R7-20250501","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.hcl.2012.08.003","article-title":"Advances in the management of Dupuytren disease: Collagenase.","volume":"28","author":"Hentz","year":"2012","journal-title":"Hand Clin"},{"key":"R8-20250501","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJMoa0810866","article-title":"Injectable collagenase clostridium histolyticum for Dupuytren\u2019s contracture.","volume":"361","author":"Hurst","year":"2009","journal-title":"N Engl J Med"},{"key":"R9-20250501","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/SAP.0000000000001068","article-title":"Outcome of Dupuytren contractures after collagenase clostridium histolyticum injection: A single-institution experience.","volume":"79","author":"Hwee","year":"2017","journal-title":"Ann Plast Surg"},{"key":"R10-20250501","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1558944716647101","article-title":"Trends in the treatment of Dupuytren disease in the United States between 2007 and 2014.","volume":"12","author":"Lipman","year":"2017","journal-title":"Hand (N Y)"},{"key":"R11-20250501","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.jhsa.2013.08.114","article-title":"Collagenase clostridium histolyticum for Dupuytren contracture: Patterns of use and effectiveness in clinical practice.","volume":"38","author":"Peimer","year":"2013","journal-title":"J Hand Surg Am"},{"key":"R12-20250501","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/1753193414528843","article-title":"Safety and tolerability of collagenase clostridium histolyticum and fasciectomy for Dupuytren\u2019s contracture.","volume":"40","author":"Peimer","year":"2015","journal-title":"J Hand Surg Eur Vol"},{"key":"R13-20250501","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/SAP.0b013e31827ae9d0","article-title":"Analysis of efficacy and safety of treatment with collagenase clostridium histolyticum among subgroups of patients with Dupuytren contracture.","volume":"73","author":"Raven","year":"2014","journal-title":"Ann Plast Surg"},{"key":"R14-20250501","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1302\/0301-620X.100B1.BJJ-2017-0463.R1","article-title":"Efficacy and adverse effects of collagenase use in the treatment of Dupuytren\u2019s disease: A meta-analysis.","volume":"100-B","author":"Sanjuan-Cerver\u00f3","year":"2018","journal-title":"Bone Joint J"},{"key":"R15-20250501","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/1753193415617385","article-title":"One-year results of needle fasciotomy and collagenase injection in treatment of Dupuytren\u2019s contracture: A two-centre prospective randomized clinical trial.","volume":"41","author":"Scherman","year":"2016","journal-title":"J Hand Surg Eur Vol"},{"key":"R16-20250501","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11552-014-9645-7","article-title":"Postapproval clinical experience in the treatment of Dupuytren\u2019s contracture with collagenase clostridium histolyticum (CCH): The first 1,000 days.","volume":"9","author":"Schulze","year":"2014","journal-title":"Hand (N Y)"},{"key":"R17-20250501","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jhsa.2017.03.003","article-title":"Injectable collagenase versus percutaneous needle fasciotomy for Dupuytren contracture in proximal interphalangeal joints: A randomized controlled trial.","volume":"42","author":"Skov","year":"2017","journal-title":"J Hand Surg Am"},{"key":"R18-20250501","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jhsa.2016.06.014","article-title":"Comparison of treatment outcome after collagenase and needle fasciotomy for Dupuytren contracture: A randomized, single-blinded, clinical trial with a 1-year follow-up.","volume":"41","author":"Str\u00f6mberg","year":"2016","journal-title":"J Hand Surg Am"},{"key":"R19-20250501","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.hansur.2017.06.007","article-title":"Efficacy and safety of collagenase treatment for Dupuytren\u2019s disease: 2-year follow-up results.","volume":"36","author":"Van Beeck","year":"2017","journal-title":"Hand Surg Rehabil"},{"key":"R20-20250501","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/2000656X.2016.1159568","article-title":"Collagenase clostridium histolyticum: Emerging practice patterns and treatment advances.","volume":"50","author":"Warwick","year":"2016","journal-title":"J Plast Surg Hand Surg"},{"key":"R21-20250501","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/1753193413519926","article-title":"Collagenase clostridium histolyticum in patients with Dupuytren\u2019s contracture: Results from POINT X, an open-label study of clinical and patient-reported outcomes.","volume":"40","author":"Warwick","year":"2015","journal-title":"J Hand Surg Eur Vol"},{"key":"R22-20250501","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/1753193415600670","article-title":"New insights into the immediate outcome of collagenase injections for Dupuytren\u2019s contracture.","volume":"41","author":"Warwick","year":"2016","journal-title":"J Hand Surg Eur Vol"},{"key":"R23-20250501","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jhsa.2010.01.003","article-title":"Collagenase injection as nonsurgical treatment of Dupuytren\u2019s disease: 8-year follow-up.","volume":"35","author":"Watt","year":"2010","journal-title":"J Hand Surg Am"},{"key":"R24-20250501","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jhsa.2012.10.008","article-title":"Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: Short-term results from 2 open-label studies.","volume":"38","author":"Witthaut","year":"2013","journal-title":"J Hand Surg Am"},{"key":"R25-20250501","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jhsa.2016.07.090","article-title":"The impact of collagenase clostridium histolyticum introduction on Dupuytren treatment patterns in the United States.","volume":"41","author":"Zhao","year":"2016","journal-title":"J Hand Surg Am"},{"key":"R26-20250501","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/PRS.0000000000001320","article-title":"Collagenase clostridium histolyticum versus limited fasciectomy for Dupuytren\u2019s contracture: Outcomes from a multicenter propensity score matched study.","volume":"136","author":"Zhou","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"R27-20250501","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jhsa.2013.10.002","article-title":"Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures.","volume":"39","author":"Coleman","year":"2014","journal-title":"J Hand Surg Am"},{"key":"R28-20250501","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12891-017-1713-z","article-title":"Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: A randomized controlled trial.","volume":"18","author":"Costas","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"key":"R29-20250501","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/2000656X.2018.1484753","article-title":"A post hoc analysis of Dupuytren contracture treated with collagenase Clostridium histolyticum across disease stages.","volume":"52","author":"Pess","year":"2018","journal-title":"J Plast Surg Hand Surg"},{"key":"R30-20250501","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2106\/JBJS.17.01128","article-title":"Percutaneous needle fasciotomy versus collagenase treatment for Dupuytren contracture: A randomized controlled trial with a two-year follow-up.","volume":"100","author":"Str\u00f6mberg","year":"2018","journal-title":"J Bone Joint Surg Am"},{"key":"R31-20250501","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1558944718787281","article-title":"Dupuytren disease management trends: A survey of hand surgeons.","volume":"15","author":"Carr","year":"2020","journal-title":"Hand (N Y)"},{"key":"R32-20250501","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jhsa.2016.03.003","article-title":"Patient satisfaction with collagenase.","volume":"41","author":"Bradley","year":"2016","journal-title":"J Hand Surg Am"},{"key":"R33-20250501","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.jhsa.2010.08.007","article-title":"Injectable collagenase clostridium histolyticum: A new nonsurgical treatment for Dupuytren\u2019s disease.","volume":"35","author":"Gilpin","year":"2010","journal-title":"J Hand Surg Am"},{"key":"R34-20250501","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhsa.2014.10.052","article-title":"Collagenase injections in patients on warfarin.","volume":"40","author":"Dickson","year":"2015","journal-title":"J Hand Surg Am"},{"key":"R35-20250501","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jhsa.2014.03.016","article-title":"Technical tips for collagenase injection treatment for Dupuytren contracture.","volume":"39","author":"Meals","year":"2014","journal-title":"J Hand Surg Am"},{"key":"R36-20250501","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.nec.2018.06.003","article-title":"Anticoagulants: Pharmacokinetics, mechanisms of action, and indications.","volume":"29","author":"DeWald","year":"2018","journal-title":"Neurosurg Clin N Am"},{"key":"R37-20250501","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1001\/jamasurg.2017.3927","article-title":"Assessing the necessity of stopping antithrombotic agents before wide-awake hand surgery.","volume":"153","author":"Sasor","year":"2018","journal-title":"JAMA Surg"},{"key":"R38-20250501","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11552-012-9407-3","article-title":"Nonsurgical treatment of Dupuytren\u2019s contracture: 1-year US post-marketing safety data for collagenase clostridium histolyticum.","volume":"7","author":"Peimer","year":"2012","journal-title":"Hand (N Y)"},{"key":"R39-20250501","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jhsa.2012.09.028","article-title":"Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data.","volume":"38","author":"Peimer","year":"2013","journal-title":"J Hand Surg Am"},{"key":"R40-20250501","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.jhsa.2015.04.036","article-title":"Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-year data.","volume":"40","author":"Peimer","year":"2015","journal-title":"J Hand Surg Am"},{"key":"R41-20250501","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.hansur.2017.07.002","article-title":"Complications after treating Dupuytren\u2019s disease: A systematic literature review.","volume":"36","author":"Krefter","year":"2017","journal-title":"Hand Surg Rehabil"},{"key":"R42-20250501","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s11552-014-9714-y","article-title":"Delayed manipulation after collagenase clostridium histolyticum injection for Dupuytren contracture.","volume":"10","author":"Kaplan","year":"2015","journal-title":"Hand (N Y)"},{"key":"R43-20250501","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.jhsa.2014.07.010","article-title":"Prospective randomized controlled trial comparing 1- versus 7-day manipulation following collagenase injection for Dupuytren contracture.","volume":"39","author":"Mickelson","year":"2014","journal-title":"J Hand Surg Am"},{"key":"R44-20250501","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jhsa.2008.05.026","article-title":"Perioperative management of systemic oral anticoagulants in patients having outpatient hand surgery.","volume":"33","author":"Lindsley","year":"2008","journal-title":"J Hand Surg Am"}],"container-title":["Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000009038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:17:40Z","timestamp":1746145060000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000009038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,11]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/prs.0000000000009038","relation":{},"ISSN":["0032-1052"],"issn-type":[{"type":"print","value":"0032-1052"}],"subject":[],"published":{"date-parts":[[2022,3,11]]}}}